PHIBRO ANIMAL HEALTH CORP (NASDAQ:PAHC) Institutional Investors Quarterly Sentiment

May 22, 2018 - By Dolores Ford

Sentiment for PHIBRO ANIMAL HEALTH CORP (NASDAQ:PAHC)

PHIBRO ANIMAL HEALTH CORP (NASDAQ:PAHC) institutional sentiment decreased to 1.41 in 2017 Q4. Its down -0.07, from 1.48 in 2017Q3. The ratio has worsened, as 83 hedge funds increased or started new positions, while 59 decreased and sold their equity positions in PHIBRO ANIMAL HEALTH CORP. The hedge funds in our partner’s database now own: 19.14 million shares, down from 19.38 million shares in 2017Q3. Also, the number of hedge funds holding PHIBRO ANIMAL HEALTH CORP in their top 10 positions increased from 0 to 1 for an increase of 1. Sold All: 17 Reduced: 42 Increased: 58 New Position: 25.

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition firm primarily in the United States. The company has market cap of $1.84 billion. It operates through three divisions: Animal Health, Mineral Nutrition, and Performance Products. It has a 31.6 P/E ratio. The firm develops, makes, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

The stock increased 0.44% or $0.2 during the last trading session, reaching $45.5. About 69,643 shares traded. Phibro Animal Health Corporation (NASDAQ:PAHC) has risen 41.44% since May 22, 2017 and is uptrending. It has outperformed by 29.89% the S&P500.

Analysts await Phibro Animal Health Corporation (NASDAQ:PAHC) to report earnings on August, 29. They expect $0.44 earnings per share, up 12.82 % or $0.05 from last year’s $0.39 per share. PAHC’s profit will be $17.75M for 25.85 P/E if the $0.44 EPS becomes a reality. After $0.46 actual earnings per share reported by Phibro Animal Health Corporation for the previous quarter, Wall Street now forecasts -4.35 % negative EPS growth.

Copper Rock Capital Partners Llc holds 1.33% of its portfolio in Phibro Animal Health Corporation for 631,876 shares. Denver Investment Advisors Llc owns 531,560 shares or 0.89% of their US portfolio. Moreover, Menta Capital Llc has 0.56% invested in the company for 85,599 shares. The Texas-based U S Global Investors Inc has invested 0.37% in the stock. Globeflex Capital L P, a California-based fund reported 32,228 shares.

Since January 1, 0001, it had 0 insider purchases, and 13 selling transactions for $12.62 million activity.

Phibro Animal Health Corporation (NASDAQ:PAHC) Ratings Coverage

Ratings analysis reveals 33% of Phibro Animal Health’s analysts are positive. Out of 3 Wall Street analysts rating Phibro Animal Health, 1 give it “Buy”, 1 “Sell” rating, while 1 recommend “Hold”. The lowest target is $36 while the high is $45.0. The stock’s average target of $41 is -9.89% below today’s ($45.5) share price. PAHC was included in 4 notes of analysts from February 6, 2018. Morgan Stanley maintained it with “Underweight” rating and $36 target in Wednesday, February 7 report. The rating was maintained by Credit Suisse with “Neutral” on Wednesday, May 9. The firm has “Buy” rating by Piper Jaffray given on Wednesday, February 7. The company was maintained on Tuesday, February 6 by Credit Suisse.

More recent Phibro Animal Health Corporation (NASDAQ:PAHC) news were published by: Globenewswire.com which released: “Phibro Animal Health Corporation Declares Quarterly Dividend” on May 07, 2018. Also Seekingalpha.com published the news titled: “Phibro Animal Health’s (PAHC) Management on Q3 2018 Results – Earnings Call Transcript” on May 11, 2018. Nasdaq.com‘s news article titled: “Research Report Identifies Albany International, JBG SMITH Properties, Preferred Apartment Communities, National …” with publication date: April 30, 2018 was also an interesting one.

Phibro Animal Health Corporation (NASDAQ:PAHC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: